NASDAQ : JANX
Janux Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 17.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.09B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Janux Therapeutics, Inc. (JANX) reported revenue of 24.00M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 24.00M | 10.00M | 10.59M | 8.08M | 8.61M | 3.64M |
| Cost of Revenue | 123.98M | 125.90M | 68.39M | 54.92M | 53.44M | 26.24M |
| Gross Profit | -99.98M | -115.90M | -57.80M | -46.84M | -44.83M | -22.60M |
| Selling, General & Admin | 43.57M | 41.77M | 41.05M | 26.14M | 22.26M | 10.33M |
| Operating Expenses | 43.57M | 41.77M | 41.05M | 26.14M | 22.26M | 10.33M |
| Operating Income | -143.56M | -157.67M | -98.85M | -72.98M | -67.09M | -32.93M |
| Interest & Investment Income | 40.96M | 44.04M | 29.85M | 14.69M | 4.03M | 257.00K |
| EBT Excluding Unusual Items | -102.59M | -113.62M | -68.99M | -58.29M | -63.06M | -32.67M |
| Pretax Income | -102.59M | -113.62M | -68.99M | -58.29M | -63.06M | -32.67M |
| Net Income | -102.59M | -113.62M | -68.99M | -58.29M | -63.06M | -32.67M |
| Net Income to Common | -102.59M | -113.62M | -68.99M | -58.29M | -63.06M | -32.67M |
| Shares Outstanding (Basic) | 62.44M | 61.97M | 53.75M | 44.02M | 41.47M | 23.53M |
| Shares Outstanding (Diluted) | 62.44M | 61.97M | 53.75M | 44.02M | 41.47M | 23.53M |
| EPS (Basic) | -1.64 | -1.83 | -1.28 | -1.32 | -1.52 | -1.39 |
| EPS (Diluted) | -1.64 | -1.83 | -1.28 | -1.32 | -1.52 | -1.39 |
| Free Cash Flow | -41.92M | -83.28M | -44.17M | -52.42M | -49.37M | -18.46M |
| Free Cash Flow Per Share | -0.67 | -1.34 | -0.82 | -1.19 | -1.19 | -0.78 |
| Operating Margin | -598.15% | -1,576.67% | -933.58% | -902.87% | -779.04% | -905.39% |
| Profit Margin | -427.47% | -1,136.25% | -651.62% | -721.18% | -732.22% | -898.32% |
| Free Cash Flow Margin | -174.69% | -832.78% | -417.20% | -648.58% | -573.24% | -507.51% |
| EBITDA | -141.65M | -155.64M | -96.79M | -71.02M | -66.25M | -32.82M |
| D&A For EBITDA | 1.90M | 2.03M | 2.06M | 1.96M | 841.00K | 113.00K |
| EBIT | -143.56M | -157.67M | -98.85M | -72.98M | -67.09M | -32.93M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 27.77M | 52.33M | 430.61M | 19.20M | 51.43M | 35.58M |
| Short-Term Investments | 943.14M | 914.23M | 594.57M | 324.82M | 275.59M | 339.38M |
| Cash & Short-Term Investments | 970.91M | 966.57M | 1.03B | 344.03M | 327.02M | 374.96M |
| Accounts Receivable | 149.00K | |||||
| Other Receivables | 6.18M | 6.43M | 5.38M | 2.16M | 700.00K | 200.00K |
| Receivables | 6.33M | 6.43M | 5.38M | 2.16M | 700.00K | 200.00K |
| Prepaid Expenses | 6.10M | 2.89M | 3.11M | 3.05M | 4.72M | 1.85M |
| Total Current Assets | 983.34M | 975.89M | 1.03B | 349.24M | 332.44M | 377.02M |
| Property, Plant & Equipment | 20.59M | 22.25M | 24.15M | 27.84M | 29.36M | 1.60M |
| Other Long-Term Assets | 3.73M | 3.42M | 3.70M | 3.33M | 2.21M | 1.21M |
| Total Assets | 1.01B | 1.00B | 1.06B | 380.41M | 364.01M | 379.82M |
| Accounts Payable | 3.02M | 4.97M | 4.03M | 2.42M | 2.16M | 2.46M |
| Accrued Expenses | 19.51M | 17.63M | 11.68M | 7.39M | 8.18M | 3.78M |
| Current Portion of Leases | 2.55M | 2.39M | 1.75M | 1.52M | 763.00K | 194.00K |
| Current Unearned Revenue | 35.07M | 1.71M | 5.41M | 5.16M | ||
| Other Current Liabilities | 1.20M | |||||
| Total Current Liabilities | 60.15M | 25.00M | 17.46M | 13.03M | 16.51M | 12.80M |
| Long-Term Leases | 18.44M | 19.75M | 21.28M | 23.02M | 24.54M | |
| Long-Term Unearned Revenue | 1.08M | 2.22M | 700.00K | |||
| Total Liabilities | 79.67M | 44.74M | 38.73M | 36.06M | 43.27M | 13.50M |
| Common Stock | 61.00K | 60.00K | 59.00K | 46.00K | 42.00K | 41.00K |
| Additional Paid-In Capital | 1.33B | 1.30B | 1.26B | 512.40M | 432.70M | 413.97M |
| Retained Earnings | -397.71M | -351.38M | -237.76M | -168.76M | -110.47M | -47.41M |
| Comprehensive Income & Other | -2.31M | 4.32M | 2.16M | 665.00K | -1.53M | -270.00K |
| Total Common Equity | 927.98M | 956.82M | 1.02B | 344.35M | 320.74M | 366.33M |
| Shareholders' Equity | 927.98M | 956.82M | 1.02B | 344.35M | 320.74M | 366.33M |
| Total Liabilities & Equity | 1.01B | 1.00B | 1.06B | 380.41M | 364.01M | 379.82M |
| Total Debt | 20.99M | 22.14M | 23.02M | 24.54M | 25.30M | 194.00K |
| Net Cash (Debt) | 949.92M | 944.43M | 1.00B | 319.49M | 301.71M | 374.77M |
| Net Cash Per Share | 15.21 | 15.24 | 18.64 | 7.26 | 7.28 | 15.93 |
| Filing Date Shares Outstanding | 61.14M | 60.83M | 59.11M | 51.65M | 41.76M | 41.24M |
| Total Common Shares Outstanding | 61.08M | 60.38M | 59.06M | 46.24M | 41.62M | 41.24M |
| Working Capital | 923.18M | 950.89M | 1.02B | 336.21M | 315.93M | 364.22M |
| Book Value Per Share | 15.19 | 15.85 | 17.32 | 7.45 | 7.71 | 8.88 |
| Tangible Book Value | 927.98M | 956.82M | 1.02B | 344.35M | 320.74M | 366.33M |
| Tangible Book Value Per Share | 15.19 | 15.85 | 17.32 | 7.45 | 7.71 | 8.88 |
| Machinery | 11.07M | 10.82M | 9.81M | 9.87M | 7.91M | 1.40M |
| Construction In Progress | 139.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -102.59M | -113.62M | -68.99M | -58.29M | -63.06M | -32.67M |
| Depreciation & Amortization | 1.90M | 2.03M | 2.06M | 1.96M | 841.00K | 113.00K |
| Loss (Gain) From Sale of Assets | 3.00K | |||||
| Loss (Gain) From Sale of Investments | -13.66M | -17.57M | -10.59M | -7.69M | -2.18M | -172.00K |
| Stock-Based Compensation | 36.89M | 40.22M | 33.02M | 20.00M | 17.20M | 6.91M |
| Change in Accounts Receivable | -149.00K | 8.00M | ||||
| Change in Accounts Payable | -453.00K | 977.00K | 1.58M | 277.00K | -294.00K | 2.14M |
| Change in Unearned Revenue | 36.15M | -1.71M | -5.92M | 1.76M | -2.14M | |
| Change in Other Net Operating Assets | 660.00K | 5.74M | 806.00K | -909.00K | 2.81M | 840.00K |
| Operating Cash Flow | -41.25M | -82.23M | -43.81M | -50.58M | -42.92M | -16.98M |
| Capital Expenditures | -674.00K | -1.04M | -359.00K | -1.85M | -6.45M | -1.48M |
| Investment in Securities | 8.03M | -299.94M | -257.66M | -39.34M | 64.71M | -339.48M |
| Investing Cash Flow | 7.35M | -300.98M | -258.02M | -41.19M | 58.27M | -340.96M |
| Issuance of Common Stock | 9.22M | 5.29M | 713.24M | 59.55M | 500.00K | 205.98M |
| Other Financing Activities | -347.00K | -453.00K | ||||
| Financing Cash Flow | 9.22M | 4.95M | 713.24M | 59.55M | 500.00K | 386.52M |
| Net Cash Flow | -24.68M | -378.27M | 411.40M | -32.22M | 15.84M | 28.59M |
| Free Cash Flow | -41.92M | -83.28M | -44.17M | -52.42M | -49.37M | -18.46M |
| Free Cash Flow Margin | -174.69% | -832.78% | -417.20% | -648.58% | -573.24% | -507.51% |
| Free Cash Flow Per Share | -0.67 | -1.34 | -0.82 | -1.19 | -1.19 | -0.78 |
| Levered Free Cash Flow | -16.39M | -51.27M | -26.14M | -29.52M | -30.56M | 577.38K |
| Unlevered Free Cash Flow | -16.39M | -51.27M | -26.14M | -29.52M | -30.56M | 577.38K |
| Change in Working Capital | 36.21M | 6.71M | 685.00K | -6.55M | 4.28M | 8.84M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.08B | 830.04M | 3.09B | 495.20M | 547.22M | 821.00M |
| Enterprise Value | 131.59M | -136.29M | 2.45B | 170.39M | 232.55M | 433.72M |
| Last Close Price | 17.47 | 13.80 | 53.54 | 10.73 | 13.17 | 19.73 |
| PS Ratio | 44.50 | 83.00 | 291.54 | 61.27 | 63.54 | 225.73 |
| PB Ratio | 1.15 | 0.87 | 3.02 | 1.44 | 1.71 | 2.24 |
| P/TBV Ratio | 1.15 | 0.87 | 3.02 | 1.44 | 1.71 | 2.24 |
| EV/Sales Ratio | 4.92 | 231.60 | 21.08 | 27.00 | 119.25 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.07 | 0.08 | 0.00 |
| Net Debt / Equity Ratio | -1.02 | -0.99 | -0.98 | -0.93 | -0.94 | -1.02 |
| Net Debt / EBITDA Ratio | 6.71 | 6.07 | 10.35 | 4.50 | 4.55 | 11.42 |
| Net Debt / FCF Ratio | 22.66 | 11.34 | 22.69 | 6.09 | 6.11 | 20.30 |
| Asset Turnover | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Quick Ratio | 16.25 | 38.92 | 59.03 | 26.56 | 19.85 | 29.32 |
| Current Ratio | 16.35 | 39.04 | 59.20 | 26.80 | 20.14 | 29.46 |
| Return on Equity (ROE) | -10.70% | -11.48% | -10.09% | -17.53% | -18.36% | -17.50% |
| Return on Assets (ROA) | -8.80% | -9.55% | -8.57% | -12.25% | -11.27% | -10.39% |
| Return on Capital Employed (ROCE) | -15.20% | -16.10% | -9.50% | -19.90% | -19.30% | -9.00% |
| Earnings Yield | -9.29% | -13.69% | -2.23% | -11.77% | -11.52% | -3.98% |
| FCF Yield | -3.93% | -10.03% | -1.43% | -10.59% | -9.02% | -2.25% |
| Buyback Yield / Dilution | -6.20% | -15.28% | -22.12% | -6.14% | -76.24% | -2,471.20% |